Revolutionizing cancer treatment: Harnessing the power of terrestrial microbial polysaccharides

Hao Ju1, Yang Liu2, Jun Gong2

  • 1School of Chemistry and Chemical Engineering, Harbin Institute of Technology, Harbin, Harbin 150006, PR China; Weihai Key Laboratory of Active Factor of Marine Products, Weihai Marine Organism & Medical Technology Research Institute, Harbin Institute of Technology, Weihai 264209, PR China.

Insights

Terrestrial microbial polysaccharides show promise as novel cancer drugs, with anticancer activity linked to molecular weight, solubility, and specific sugars like mannose and galactose. Further research into these natural compounds could lead to safer, more effective cancer therapies.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Current cancer treatments face challenges like poor targeting, high costs, toxicity, and limited efficacy.
  • Microbial polysaccharides, particularly from terrestrial sources, exhibit diverse biological activities, including anticancer potential.
  • There is a need for novel, safe, and effective anticancer agents.

Purpose of the Study:

  • To review and analyze the structure-activity relationships of terrestrial microbial polysaccharides against cancer.
  • To identify key factors influencing the anticancer efficacy of these natural compounds.
  • To provide insights for future development of microbial polysaccharide-based cancer therapies.

Main Methods:

  • Comprehensive literature review of anti-cancer studies on terrestrial microbial polysaccharides.
  • Analysis of research published between 2020 and 2024.
  • Evaluation of factors affecting anticancer activity, including microbial source, chemical structure, and purity.

Main Results:

  • Anticancer efficacy is influenced by microbial species, form, chemical structure, and purity.
  • Optimal molecular weight and good water solubility are crucial for anticancer activity.
  • Inclusion of mannose and galactose significantly enhances anticancer properties.

Conclusions:

  • Terrestrial microbial polysaccharides represent a promising source for developing new anticancer drugs.
  • Understanding the structure-activity relationship is key to optimizing their therapeutic potential.
  • These findings offer a valuable reference for advancing cancer drug therapy using microbial polysaccharides.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
352